Format

Send to

Choose Destination
Curr Urol Rep. 2019 May 18;20(7):36. doi: 10.1007/s11934-019-0898-0.

Nephrolithiasis in the Obese Patient.

Author information

1
University of Southampton, Southampton, UK.
2
Department of Urology, University Hospital Southampton, Tremona Road, Southampton, SO16 6YD, UK. r.geraghty@soton.ac.uk.
3
Department of Urology, University Hospital Southampton, Tremona Road, Southampton, SO16 6YD, UK.

Abstract

PURPOSE OF REVIEW:

The link between metabolic syndrome (MetS)/obesity and kidney stone disease (KSD) has gained importance over recent years due to the increasing prevalence and healthcare burden worldwide. This review analyses the literature exploring the link between MetS/obesity and KSD and the impact that obesity has on KSD management.

RECENT FINDINGS:

Metabolic syndrome has been shown to increase an individual's risk of developing kidney stone disease, with insulin resistance forming a core component of the pathophysiology. The body habitus of an individual also influences the type of intervention that is most appropriate, with flexible ureteroscopy increasingly being the preferred option in obese patients. It is important for urologists to consider the features of metabolic syndrome to effectively manage episodes of KSD in obese patients. In addition, better quality evidence is required to effectively compare different treatment options in this group of patients.

KEYWORDS:

Flexible ureteroscopy; Insulin resistance; Kidney stone disease; Metabolic syndrome; Obese; Percutaneous nephrolithotomy; RIRS; Shock wave lithotripsy; URS

PMID:
31104149
DOI:
10.1007/s11934-019-0898-0
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center